Noémie Dam
Genfit (France)(FR)
Publications by Year
Research Areas
Tissue Engineering and Regenerative Medicine, Cardiac Fibrosis and Remodeling, Signaling Pathways in Disease, Liver Disease Diagnosis and Treatment, RNA Interference and Gene Delivery
Most-Cited Works
- → A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study(2020)237 cited
- → Correction: Corrigendum: Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem/progenitor cells(2017)175 cited
- → Natural killer cell crosstalk with allogeneic human cardiac-derived stem/progenitor cells controls persistence(2014)43 cited
- → Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem/progenitor cells(2017)16 cited
- → Human Cardiac-Derived Stem/Progenitor Cells Fine-Tune Monocyte-Derived Descendants Activities toward Cardiac Repair(2017)11 cited
- → 39-OR(2013)1 cited
- → LBP03(2015)1 cited
- Allogeneic cardiac stem/progenitor cells and innate immune and humoral responses(2018)
- → Serum levels of miR-34a to rule-out NAFLD in healthy subjects and identify NAFLD patients with active NASH (NAS>= 4) and significant liver fibrosis (F >= 2)(2020)